183 related articles for article (PubMed ID: 16771834)
21. Liver X receptor agonist treatment ameliorates amyloid pathology and memory deficits caused by high-fat diet in APP23 mice.
Fitz NF; Cronican A; Pham T; Fogg A; Fauq AH; Chapman R; Lefterov I; Koldamova R
J Neurosci; 2010 May; 30(20):6862-72. PubMed ID: 20484628
[TBL] [Abstract][Full Text] [Related]
22. microRNA-33 Regulates ApoE Lipidation and Amyloid-β Metabolism in the Brain.
Kim J; Yoon H; Horie T; Burchett JM; Restivo JL; Rotllan N; Ramírez CM; Verghese PB; Ihara M; Hoe HS; Esau C; Fernández-Hernando C; Holtzman DM; Cirrito JR; Ono K; Kim J
J Neurosci; 2015 Nov; 35(44):14717-26. PubMed ID: 26538644
[TBL] [Abstract][Full Text] [Related]
23. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR.
Wong J; Quinn CM; Brown AJ
Biochem J; 2006 Dec; 400(3):485-91. PubMed ID: 16901265
[TBL] [Abstract][Full Text] [Related]
24. Deletion of Abca1 increases Abeta deposition in the PDAPP transgenic mouse model of Alzheimer disease.
Wahrle SE; Jiang H; Parsadanian M; Hartman RE; Bales KR; Paul SM; Holtzman DM
J Biol Chem; 2005 Dec; 280(52):43236-42. PubMed ID: 16207708
[TBL] [Abstract][Full Text] [Related]
25. The effect of T0901317 on ATP-binding cassette transporter A1 and Niemann-Pick type C1 in apoE-/- mice.
Dai XY; Ou X; Hao XR; Cao DL; Tang YL; Hu YW; Li XX; Tang CK
J Cardiovasc Pharmacol; 2008 May; 51(5):467-75. PubMed ID: 18437096
[TBL] [Abstract][Full Text] [Related]
26. Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain.
Hirsch-Reinshagen V; Zhou S; Burgess BL; Bernier L; McIsaac SA; Chan JY; Tansley GH; Cohn JS; Hayden MR; Wellington CL
J Biol Chem; 2004 Sep; 279(39):41197-207. PubMed ID: 15269218
[TBL] [Abstract][Full Text] [Related]
27. Bexarotene Promotes Cholesterol Efflux and Restricts Apical-to-Basolateral Transport of Amyloid-β Peptides in an In Vitro Model of the Human Blood-Brain Barrier.
Kuntz M; Candela P; Saint-Pol J; Lamartinière Y; Boucau MC; Sevin E; Fenart L; Gosselet F
J Alzheimers Dis; 2015; 48(3):849-62. PubMed ID: 26402114
[TBL] [Abstract][Full Text] [Related]
28. Improvement of memory deficits and amyloid-β clearance in aged APP23 mice treated with a combination of anti-amyloid-β antibody and LXR agonist.
Fitz NF; Castranio EL; Carter AY; Kodali R; Lefterov I; Koldamova R
J Alzheimers Dis; 2014; 41(2):535-49. PubMed ID: 24643138
[TBL] [Abstract][Full Text] [Related]
29. Expression of liver X receptor target genes decreases cellular amyloid beta peptide secretion.
Sun Y; Yao J; Kim TW; Tall AR
J Biol Chem; 2003 Jul; 278(30):27688-94. PubMed ID: 12754201
[TBL] [Abstract][Full Text] [Related]
30. 22R-hydroxycholesterol and 9-cis-retinoic acid induce ATP-binding cassette transporter A1 expression and cholesterol efflux in brain cells and decrease amyloid beta secretion.
Koldamova RP; Lefterov IM; Ikonomovic MD; Skoko J; Lefterov PI; Isanski BA; DeKosky ST; Lazo JS
J Biol Chem; 2003 Apr; 278(15):13244-56. PubMed ID: 12547833
[TBL] [Abstract][Full Text] [Related]
31. Liver X receptor agonist treatment significantly affects phenotype and transcriptome of APOE3 and APOE4 Abca1 haplo-deficient mice.
Carter AY; Letronne F; Fitz NF; Mounier A; Wolfe CM; Nam KN; Reeves VL; Kamboh H; Lefterov I; Koldamova R
PLoS One; 2017; 12(2):e0172161. PubMed ID: 28241068
[TBL] [Abstract][Full Text] [Related]
32. Brain pericytes ABCA1 expression mediates cholesterol efflux but not cellular amyloid-β peptide accumulation.
Saint-Pol J; Vandenhaute E; Boucau MC; Candela P; Dehouck L; Cecchelli R; Dehouck MP; Fenart L; Gosselet F
J Alzheimers Dis; 2012; 30(3):489-503. PubMed ID: 22433669
[TBL] [Abstract][Full Text] [Related]
33. The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease.
Riddell DR; Zhou H; Comery TA; Kouranova E; Lo CF; Warwick HK; Ring RH; Kirksey Y; Aschmies S; Xu J; Kubek K; Hirst WD; Gonzales C; Chen Y; Murphy E; Leonard S; Vasylyev D; Oganesian A; Martone RL; Pangalos MN; Reinhart PH; Jacobsen JS
Mol Cell Neurosci; 2007 Apr; 34(4):621-8. PubMed ID: 17336088
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and identification of new flavonoids targeting liver X receptor β involved pathway as potential facilitators of Aβ clearance with reduced lipid accumulation.
Hu Y; Yang Y; Yu Y; Wen G; Shang N; Zhuang W; Lu D; Zhou B; Liang B; Yue X; Li F; Du J; Bu X
J Med Chem; 2013 Aug; 56(15):6033-53. PubMed ID: 23844653
[TBL] [Abstract][Full Text] [Related]
35. [Liver X receptors mediate cholesterol efflux in mouse glomerular mesangial cells].
Yu B; Wu J; Zhang XY; Chen LH; Yang GR; Wei MF; Xing CY; Guan YF
Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 38(3):244-8. PubMed ID: 16778964
[TBL] [Abstract][Full Text] [Related]
36. The role of ATP-binding cassette transporter A1 in Alzheimer's disease and neurodegeneration.
Koldamova R; Fitz NF; Lefterov I
Biochim Biophys Acta; 2010 Aug; 1801(8):824-30. PubMed ID: 20188211
[TBL] [Abstract][Full Text] [Related]
37. The LXR agonist T0901317 promotes the reverse cholesterol transport from macrophages by increasing plasma efflux potential.
Zanotti I; Potì F; Pedrelli M; Favari E; Moleri E; Franceschini G; Calabresi L; Bernini F
J Lipid Res; 2008 May; 49(5):954-60. PubMed ID: 18252848
[TBL] [Abstract][Full Text] [Related]
38. ABCA1-dependent but apoA-I-independent cholesterol efflux mediated by fatty acid-bile acid conjugates (FABACs).
Goldiner I; van der Velde AE; Vandenberghe KE; van Wijland MA; Halpern Z; Gilat T; Konikoff FM; Veldman RJ; Groen AK
Biochem J; 2006 Jun; 396(3):529-36. PubMed ID: 16522192
[TBL] [Abstract][Full Text] [Related]
39. ATP-binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro.
Chan SL; Kim WS; Kwok JB; Hill AF; Cappai R; Rye KA; Garner B
J Neurochem; 2008 Jul; 106(2):793-804. PubMed ID: 18429932
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of steroidogenic acute regulatory protein increases macrophage cholesterol efflux to apolipoprotein AI.
Taylor JM; Borthwick F; Bartholomew C; Graham A
Cardiovasc Res; 2010 Jun; 86(3):526-34. PubMed ID: 20083572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
